NCT00312819View on ClinicalTrials.gov

Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

chemotherapy +/- disulfiram

Trial Locations (1)

Unknown

Oncology Institute Meir Medical Center, Kfar Saba

All Listed Sponsors
collaborator

Augusta Hospital, Berlin

OTHER

lead

Hadassah Medical Organization

OTHER

NCT00312819 - Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | Biotech Hunter | Biotech Hunter